HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, D. M. Articles by Haynes, B. F. Search for Related Content PubMed PubMed Citation Articles by Lee, D. M. Articles by Haynes, B. F.

Immunologic Characterization of CD7-Deficient Mice¹

David M. Lee^*, Herman F. Staats^*,, John S. Sundy^*, Dhavalkumar D. Patel^*,, Gregory D. Sempowski^*, Richard M. Scearce^*, Dawn M. Jones^* and Barton F. Haynes^2,*,

^* Division of Rheumatology, Allergy and Clinical Immunology, Department of Medicine, and Department of Immunology and the Duke University Arthritis Center, Duke University Medical Center, Durham, NC 27710

Human CD7 is an Ig superfamily molecule that is expressed on mature T and NK lymphocytes. Although in vitro studies have suggested a role for CD7 in lymphoid development and function, the exact function of CD7 in vivo has remained elusive. One patient has been reported with SCID syndrome attributed to CD7 deficiency. To study in vivo functions of CD7, we have generated CD7-deficient mice and assessed their lymphoid development and function. CD7-deficient mice were viable, had normal peripheral blood and spleen lymphocyte numbers, and had normal specific Ab responses with Ag-driven Ig isotype switching. Thymocyte numbers were normal in 4-wk-old, 6-mo-old, and 1-yr-old CD7-deficient mice, but in 3-mo-old CD7-deficient mice, total thymocyte numbers were significantly increased by 60% (p < 0.02) compared with normal age-matched +/+ littermates. CD7-deficient splenocytes proliferated normally in response to various mitogens, including PHA, anti-CD3, Con A, and LPS. While NK cell numbers and cytolytic activity to YAC targets were normal, CD7-deficient mice had lower Ag-induced MHC class I-restricted CTL activity against OVA-transfected target cells than did +/+ control mice. Thus, CD7-deficient mice did not have a SCID syndrome, but rather had transient increases in thymocyte numbers at age 3 mo and altered splenocyte Ag-specific CTL effecter cell activity. These data suggest a role for CD7 in regulating intrathymic T cell development and in mediating CTL effecter function.

This article has been cited by other articles:

				G. D. Sempowski, S. J. Cross, C. S. Heinly, R. M. Scearce, and B. F. Haynes CD7 and CD28 Are Required for Murine CD4+CD25+ Regulatory T Cell Homeostasis and Prevention of Thyroiditis J. Immunol., January 15, 2004; 172(2): 787 - 794. [Abstract] [Full Text] [PDF]

				T. Fukumori, Y. Takenaka, T. Yoshii, H.-R. C. Kim, V. Hogan, H. Inohara, S. Kagawa, and A. Raz CD29 and CD7 Mediate Galectin-3-Induced Type II T-Cell Apoptosis Cancer Res., December 1, 2003; 63(23): 8302 - 8311. [Abstract] [Full Text] [PDF]

				G. D. Sempowski, J. R. Thomasch, M. E. Gooding, L. P. Hale, L. J. Edwards, E. Ciafaloni, D. B. Sanders, J. M. Massey, D. C. Douek, R. A. Koup, et al. Effect of Thymectomy on Human Peripheral Blood T Cell Pools in Myasthenia Gravis J. Immunol., February 15, 2001; 166(4): 2808 - 2817. [Abstract] [Full Text] [PDF]

				C. S. Heinly, G. D. Sempowski, D. M. Lee, D. D. Patel, P. M. McDermott, R. M. Scearce, C. B. Thompson, and B. F. Haynes Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice Int. Immunol., February 1, 2001; 13(2): 157 - 166. [Abstract] [Full Text] [PDF]

				G. M. A. Gillespie, M. R. Wills, V. Appay, C. O'Callaghan, M. Murphy, N. Smith, P. Sissons, S. Rowland-Jones, J. I. Bell, and P. A. H. Moss Functional Heterogeneity and High Frequencies of Cytomegalovirus-Specific CD8+ T Lymphocytes in Healthy Seropositive Donors J. Virol., September 1, 2000; 74(17): 8140 - 8150. [Abstract] [Full Text]

				K. E. Pace, H. P. Hahn, M. Pang, J. T. Nguyen, and L. G. Baum Cutting Edge: CD7 Delivers a Pro-Apoptotic Signal During Galectin-1-Induced T Cell Death J. Immunol., September 1, 2000; 165(5): 2331 - 2334. [Abstract] [Full Text] [PDF]

				G. D. Sempowski, L. P. Hale, J. S. Sundy, J. M. Massey, R. A. Koup, D. C. Douek, D. D. Patel, and B. F. Haynes Leukemia Inhibitory Factor, Oncostatin M, IL-6, and Stem Cell Factor mRNA Expression in Human Thymus Increases with Age and Is Associated with Thymic Atrophy J. Immunol., February 15, 2000; 164(4): 2180 - 2187. [Abstract] [Full Text] [PDF]

				S. D. Lyman, S. Escobar, A.-M. Rousseau, A. Armstrong, and W. C. Fanslow Identification of CD7 as a Cognate of the Human K12 (SECTM1) Protein J. Biol. Chem., February 4, 2000; 275(5): 3431 - 3437. [Abstract] [Full Text] [PDF]

				G. D. Sempowski, D. M. Lee, R. M. Scearce, D. D. Patel, and B. F. Haynes Resistance of CD7-deficient Mice to Lipopolysaccharide-induced Shock Syndromes J. Exp. Med., March 15, 1999; 189(6): 1011 - 1016. [Abstract] [Full Text] [PDF]

				U Atasoy, J Watson, D Patel, and J. Keene ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation J. Cell Sci., January 11, 1998; 111(21): 3145 - 3156. [Abstract] [PDF]